A citation-based method for searching scientific literature

Elaine R Mardis, Li Ding, David J Dooling, David E Larson, Michael D McLellan, Ken Chen, Daniel C Koboldt, Robert S Fulton, Kim D Delehaunty, Sean D McGrath, Lucinda A Fulton, Devin P Locke, Vincent J Magrini, Rachel M Abbott, Tammi L Vickery, Jerry S Reed, Jody S Robinson, Todd Wylie, Scott M Smith, Lynn Carmichael, James M Eldred, Christopher C Harris, Jason Walker, Joshua B Peck, Feiyu Du, Adam F Dukes, Gabriel E Sanderson, Anthony M Brummett, Eric Clark, Joshua F McMichael, Rick J Meyer, Jonathan K Schindler, Craig S Pohl, John W Wallis, Xiaoqi Shi, Ling Lin, Heather Schmidt, Yuzhu Tang, Carrie Haipek, Madeline E Wiechert, Jolynda V Ivy, Joelle Kalicki, Glendoria Elliott, Rhonda E Ries, Jacqueline E Payton, Peter Westervelt, Michael H Tomasson, Mark A Watson, Jack Baty, Sharon Heath, William D Shannon, Rakesh Nagarajan, Daniel C Link, Matthew J Walter, Timothy A Graubert, John F DiPersio, Richard K Wilson, Timothy J Ley. N Engl J Med 2009
Times Cited: 1582



Peter Paschka, Richard F Schlenk, Verena I Gaidzik, Marianne Habdank, Jan Krönke, Lars Bullinger, Daniela Späth, Sabine Kayser, Manuela Zucknick, Katharina Götze, Heinz-A Horst, Ulrich Germing, Hartmut Döhner, Konstanze Döhner. J Clin Oncol 2010
Times Cited: 546




List of shared articles



Times cited

IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.
Badder Kattih, Amir Shirvani, Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, Maximilian Brandes, Anuhar Chaturvedi, Timon Seeger, Felicitas Thol,[...]. Leukemia 2021
5

Human hematopoiesis: aging and leukemogenic risk.
Emmalee R Adelman, Maria E Figueroa. Curr Opin Hematol 2021
0

Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
Xiao Chen, Han Zhu, Chun Qiao, Sishu Zhao, Lu Liu, Yan Wang, Huimin Jin, Sixuan Qian, Yujie Wu. Hematology 2021
1

Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Evan C Chen, Shuli Li, Ann-Kathrin Eisfeld, Marlise R Luskin, Alice Mims, Daniel Jones, Joseph H Antin, Corey S Cutler, John Koreth, Vincent T Ho,[...]. Transplant Cell Ther 2021
0

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm.
Ghayas C Issa, Courtney D DiNardo. Blood Cancer J 2021
0


Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation.
James Yu, Jingxin Sun, Yuan Du, Rushang Patel, Juan Carlos Varela, Shahram Mori, Chung-Che Chang. Diagnostics (Basel) 2021
0

Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Jingtao Lu, Meiyu Chen, Haiying Hua, Wei Qin, Ri Zhang, Xuzhang Lu, Hongying Chao. Int J Lab Hematol 2021
0


IDH Inhibitors in AML-Promise and Pitfalls.
Hannah McMurry, Luke Fletcher, Elie Traer. Curr Hematol Malig Rep 2021
0

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Marta Libura, Emilia Bialopiotrowicz, Sebastian Giebel, Agnieszka Wierzbowska, Gail J Roboz, Beata Piatkowska-Jakubas, Marta Pawelczyk, Patryk Gorniak, Katarzyna Borg, Magdalena Wojtas,[...]. Sci Rep 2021
0

SOHO State of the Art Updates and Next Questions: IDH Inhibition.
Matteo Dragani, Stéphane de Botton. Clin Lymphoma Myeloma Leuk 2021
0

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.
Cristina Panuzzo, Elisabetta Signorino, Chiara Calabrese, Muhammad Shahzad Ali, Jessica Petiti, Enrico Bracco, Daniela Cilloni. J Clin Med 2020
9

Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation.
Justin S Becker, Amir T Fathi. Curr Cancer Drug Targets 2020
5